Welcome to the Neuroscience and Neurodegeneration Research Group
The Neuroscience Research Group investigates neurophysiological and pathophysiological processes in the brain. It is headed by Dr. Christian Hölscher.
The main focus of research of the group is to analyse the processes in the brain that underlie Alzheimer’s disease. In particular, the recently described connection between type 2 diabetes and Alzheimer’s disease is under investigation, and several novel peptides that have been developed by the diabetes research group at UU are tested in models of Alzheimer’s disease. Novel drugs developed to treat type 2 diabetes have shown impressive effects in reducing neurodegenerative symptoms in models of Alzheimer’s disease. A clinical trial to test a peptide drug in patients with Alzheimer’s disease is currently ongoing.